BD Veritor™ Plus System
for Rapid Detection of
Group A Strep
The BD Veritor™ Plus System test for Group A Strep for simple streptococcus testing, with results delivered in just 5 minutes.
Contact Us
Efficient Group A Strep testing.
The BD Veritor™ Plus System is designed to offer simple Group A Strep testing, with results delivered in just 5 minutes.
BD Veritor™ Plus System for Rapid Detection of Group A Strep (CLIA-waived kit) offers proven performance vs culture
| Sensitivity | Specificity | Results in |
Throat swab sample | 96.6% (95% CI: 92.4%, 98.6%) | 95.5% (95% CI: 93.6%, 96.9%) |
5 minutes
|
Ordering information | Cat no. | Qty |
BD Veritor™ Plus System Group A Strep kit | 256040 | 30 tests |
BD Veritor™ Plus Analyzer | 256066 | 1 unit |
Get more answers with every sample.
Simplifies the testing process
- Easy operation with single-button functionality that can potentially reduce manual test processing errors
- Provides intuitive sample processing with prefilled, unitized tubes
Delivers workflow efficiency
Adapts easily to your workflow by offering 2 operational modes
- Walk Away: the test device is inserted into the Analyzer immediately after preparation, allowing staff to multitask while the sample incubates
- Analyze Now: the test device is inserted after the incubation time is complete, allowing batches of samples to be tested at once
Provides results traceability
- Downloadable lot number, patient/specimen ID, operator ID entry capability and test records with the BD Veritor™ InfoWiFi module or via the companion ImageMover application
- Offers result printing capabilities via USB port
Achieves reliable, rapid results
- Displays easy-to-read digital results for Group A Strep in just 5 minutes1
- Provides clear, objective results by correcting for nonspecific binding and detecting faint lines not recognized by the unaided eye5
Contact a Sales Representative to get your organization’s
diagnostic testing program started today
BD Veritor™ Plus System Support & Training
See how BD supports you with tools, education, and training—enabling a streamlined point-of-care experience for those you serve, and confidence in your results.
Professional Care Testing
The BD Veritor™ Plus System enhances point-of-care testing for COVID-19, Flu A+B, COVID-19 & Flu A+B,* RSV and Group A Strep, providing rapid diagnostic testing in a convenient, portable instrument.
1. BD Veritor™ Plus System for Rapid Detection of Group A Strep. Package insert. 8087667 Becton, Dickinson and Company.
BD Life Sciences, 7 Loveton Circle, Sparks, MD 21152-0999 USA 800-638-8663
*In the USA, the BD Veritor™ System for Rapid Detection of SARS-CoV-2 & Flu A+B has not been FDA cleared or approved but has been authorized by the FDA under an Emergency Use Authorization for use by authorized laboratories; use by laboratories certified under the CLIA, 42 U.S.C. §263a, that meet requirements to perform moderate, high, or waived complexity tests. The product is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
This product has been authorized only for the detection of proteins from SARS-CoV-2, influenza A and influenza B, not for any other viruses or pathogens; and, in the USA, the emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID 19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. §360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
BD, the BD Logo, and BD Veritor are trademarks of Becton, Dickinson and Company or its affiliates. © 2025 BD. All rights reserved.
bd.com